Featured News
More News
Drs. Addala, Chou, Gloyn, Lal spoke to The SugarScience on flexing innovations in genetics, insulin bioengineering, & diabetes tech to advance health equity in diabetes diagnosis & management
Drs. Ananta Addala, Danny Chou, Anna Gloyn and Rayhan Lal spoke to The SugarScience on flexing innovations in genetics, insulin bioengineering, and diabetes technology to advance health equity in diabetes diagnosis and management.
Why precision medicine leads to better diabetes care, a comprehensive report with contributions from Jessie Wong, SDRC Affinity leaders Anna Gloyn and Korey Hood, and SDRC member Jennifer Ikle
Diabetes can show up in almost anyone: pregnant women, babies, kids, teens, adults both young and old.
But the condition's various forms, all of which affect how the body processes blood sugar, can manifest quite differently in the hundreds of millions of people worldwide who have the disease -- making it perfect for the individualized approach known as precision medicine, Stanford Medicine researchers say.
National Programs that Train Physician-Scientists Focused on Diabetes Research, and Led By SDRC Co-Director David Maahs, Garner Support and Recognition
Helmsley Trust and NIDDK provide crucial support for physician-scientist training in diabetes research.
SDRC researchers including Dr. Michael Snyder take part in HuBMAP, showing what healthy human tissue looks like
Stanford Medicine scientists describe details of the human intestine and placental tissue as part of the National Institute of Health’s Human Biomolecular Atlas Program.
Study by Dr. Anisha Patel: Water promotion in schools may help prevent unhealthy weight gain
Encouraging children to drink more water and increasing their access to it at school may help prevent unhealthy weight gain, according to a new study in California elementary schools.
Using an AI-based algorithm, Katrin Svensson, PhD, and lead researcher Laetitia Coassolo, PhD, identified a 12-amino acid peptide that suppresses appetite and promotes weight loss in mice and minipigs by activating different metabolic and neuronal pathways than GLP-1.